Scientific article

Connectivites et grossesse

Published inRevue médicale suisse, vol. 19, no. 821, p. 686-692
Publication date2023-04-05

Connective tissue diseases are rare usually affecting women of reproductive age. Patients should be informed about the potential obstetrical risks associated with their disease as well as potential exacerbations during pregnancy, while simultaneously being reassured with the prospect of a positive pregnancy outcome. In recent years, significant progress has been made in medical treatments, giving women the opportunity to consider pregnancy. Preconception counseling is critical to pregnancy planning. An effective contraceptive measure should be recommended based on disease activity and teratogenic medications should be modified. Pregnancy monitoring are managed based on specific clinical and serological markers (such as the presence of anti-SSA/SSB or anti-phospholipid antibodies). A multidisciplinary approach is essential for a safe pregnancy.

  • Pregnancy
  • Humans
  • Female
  • Pregnancy Outcome
  • Family Planning Services
  • Contraception
  • Contraceptive Agents
  • Connective Tissue Diseases
  • Pregnancy Complications / epidemiology
  • Pregnancy Complications / etiology
  • Pregnancy Complications / therapy
Citation (ISO format)
PHAM-NGUYEN, Thi Minh Chau, NIGOLIAN, Haig, ALLALI, Danièle. Connectivites et grossesse. In: Revue médicale suisse, 2023, vol. 19, n° 821, p. 686–692. doi: 10.53738/REVMED.2023.19.821.686
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 10/06/2024
ISSN of the journal1660-9379

Technical informations

Creation10/06/2023 8:49:11 AM
First validation02/21/2024 9:36:30 AM
Update time02/21/2024 9:36:30 AM
Status update02/21/2024 9:36:30 AM
Last indexation05/06/2024 5:58:35 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack